Reassessing the Benefits and Risks of Alosetron Viola AndresenStephan Hollerbach Current Opinion 20 November 2012 Pages: 283 - 292
The Xyrem® Risk Management Program David E. FullerCarl S. HornfeldtTodd F. Anderson Leading Article 20 November 2012 Pages: 293 - 306
Safety of Tumour Necrosis Factor-α Antagonists Dinesh KhannaMaureen McMahonDaniel E. Furst Review Article 20 November 2012 Pages: 307 - 324
Does Paracetamol Potentiate the Effects of Oral Anticoagulants? Isabelle MahéCharles CaulinJean-François Bergmann Review Article 20 November 2012 Pages: 325 - 333
Safety of Telmisartan in Patients with Arterial Hypertension Martin C. MichelHerbert BohnerUwe Heemann Original Research Article 20 November 2012 Pages: 335 - 344
Leflunomide for the Treatment of Rheumatoid Arthritis in Clinical Practice Eric N. van RoonTim L.Th.A. JansenJacobus R.B.J. Brouwers Original Research Article 20 November 2012 Pages: 345 - 352